Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, announced Lucem Health has selected Amendola to execute an integrated PR and marketing program to position the company as a leader in AI-powered early disease detection.
Lucem Health, which was started by Mayo Clinic and is based in Raleigh, N.C., offers a portfolio of AI-driven solutions for identifying undiagnosed patients with certain chronic diseases before symptoms emerge using only their EHR records. It has solutions specifically for arrhythmias, colorectal cancer, liver disease, and type 1 diabetes. Amendola is providing a comprehensive PR and marketing program to showcase these revolutionary screenings, which can be done automatically without patient involvement or disruption of providers’ workflows.
“Too often, providers are forced to react to disease after it has progressed,” said Sean Cassidy, CEO and Co–Founder of Lucem Health. “By helping caregivers proactively identify patients with undiagnosed disease, we enable earlier engagement, more effective interventions, and better outcomes. We partnered with Amendola to help bring this story to market.”
Agency president Jodi Amendola said: “Leveraging AI to identify people at greater risk of serious disease by using clinically trained algorithms to detect patterns in their medical records is surely one of the marvels of modern healthcare technology. We’re excited to help raise awareness of Lucem Health’s solutions through PR, social media, and marketing programs.”
For more such updates, follow us on Google News Martech News
